Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03911375
Other study ID # FIBEA-01-EC/18/MIND
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 3, 2019
Est. completion date March 30, 2020

Study information

Verified date July 2021
Source Fundación Eduardo Anitua
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the influence of stress on inflammation and the symptomatology of the patient with back pain. Mindfulness Based Stress Reduction (MBSR) will be used in half of participants, a validated psychopedagogical intervention for stress reduction, and the participants assigned to the control group will follow the usual treatment, according to their diagnosis.


Description:

The Mindfulness based stress reduction (MBSR) is a psycho-educational program of stress reduction based on mindfulness. It consists of a program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between the week 6 and 7 of the program with a duration of 7.5 hours. Each week, the theoretical contents that are necessary to understand the attention development practices will be covered. In addition, basic concepts of the psychobiology and psychology of stress and pain will be explained. The subjects will have a homework load of approximately 45 minutes per day during the intervention program.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date March 30, 2020
Est. primary completion date March 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - To be diagnosed with symptomatic disc disease (Participants must provide a medical report that certifies the discopathy). - Normal or moderate mobility - Normal cognitive state - Patients who have previously read and signed the informed consent. - Patients that are capable and willing to comply with the study procedures. Exclusion Criteria: - Serious psychopathologies - Suicidal thoughts. - Deep depression - Psychosis - Drug addiction - Very limited functional capacity and cognitive impairment: Patientsconfined in a bed or a chair. They need the help of a third person. - Do not incorporate during the program any clinical, psychological or pharmacological treatments different from those ones that are normally used to controlled the pain, or any drastic changes in lifestyle.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mindfulness Based Stress Reduction (MBSR)
Psycho-educational program of stress reduction based on mindfulness. Program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between week 6 and 7 of the program with a duration of 7.5 hours. Each week the theoretical contents necessary to understand the attention development practices proposed in mindfulness-based interventions will be covered. In addition, basic concepts of the psychobiology and psychology of stress and pain are explained. The subjects will have a homework load of approximately 45 minutes per day during the duration of the intervention.

Locations

Country Name City State
Spain Facultad de Psicología de la Universidad Complutense de Madrid. Madrid Somosaguas
Spain Instituto de Investigación y Formación en Ciencias Cognitivas - Nirakara Madrid Colmenarejo
Spain Fundación Eduardo Anitua Vitoria Alava

Sponsors (3)

Lead Sponsor Collaborator
Fundación Eduardo Anitua Instituto de Investigación y Formación en Ciencias Cognitivas - Nirakara, Universidad Complutense de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stress change Measured with the variation of cortisol in blood. These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs. Baseline and Six months
Primary Variation of cytokines ((TNF) -a and interleukin (IL) -1ß, IL-6 and IL17), as an approximate biomarker of inflammation. Bio-chemical markers of the discopathy: Cytokines ((TNF) -a, interleukin (IL) -1ß, IL-6 and IL-17). These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs. Baseline and Six months
Primary Variation of the nocturnal apnea index. Sleep and breathing analysis: The performance of the sleep and breathing registration tests will be carried out in the patient's home. The sleep study will be done with a validated respiratory polygraphy (BTI-APNiA®). The sleep analysis will be controlled by a sleep technician and supervised by a sleep medicine specialist. The sleep analysis will be done to the participants before and after starting the experimental and control programs. Baseline and Six months
Secondary Five Facet Mindfulness Questionnaire (FFMQ) 39 items scale that offers a total score of a person's level of mindfulness. Baseline and Six months
Secondary Self-Compassion Scale (SCS) Evaluates the person's ability to be kind and understanding with themselves. The scale consists of 26 items scored on a 5-point likert scale. Baseline and Six months
Secondary Perceived Stress Scale (PSS) Evaluates the level of perceived stress during the last month. It consists of 14 items scored on a Likert scale from 0 to 4. Baseline and Six months
Secondary DASS-21 Scale designed to assess negative mood by means of three subscales: stress, anxiety and depression. The scale has 21 items scored on a Likert scale from 0 to 3. Baseline and Six months
Secondary Chronic Pain Grade Scale (CPGS; 90) Scale that assesses the intensity of pain and disability caused by pain. It is a widely used measure for the evaluation of chronic musculoskeletal pain and back pain. The scale consists of 7 items scored on a Likert scale from 0 to 10. Baseline and Six months
Secondary Brief Pain Inventory (BPI) It measures both the intensity of pain (sensory dimension) and the interference of pain in the patient's life (reactive dimension) in patients with chronic pain caused by osteoarthritis, back pain and cancer. Baseline and Six months
Secondary Chronic Pain Acceptance Questionnaire-Revised (CPAQ-R) Instrument designed to assess the acceptance of pain. The scale consists of 20 items scored on a Likert scale from 0 to 6. Baseline and Six months
Secondary Pain Catastrophising Scale (PCS) Evaluates the tendency to magnify the threat of a painful stimulus and the feeling of helplessness in the presence of pain, as well as the inability to prevent or inhibit thoughts related to pain (both before, during, and after the painful event). The scale consists of 13 items scored on a Likert scale from 0 to 4. Baseline and Six months
Secondary Brief Fatigue Inventory (BFI) The objective of this scale is to assess the severity of fatigue and the impact of fatigue caused by pain in the daily functioning of people. The scale consists of 9 items scored on a scale likert type from 0 to 10. Baseline and Six months
Secondary Pain Self-E?cacy Questionnaire (PSEQ) Evaluates to what extent a person with pain believes they are capable of performing their daily activities regardless of their pain. The scale consists of 10 items scored on a scale likert type from 0 to 6. Baseline and Six months
Secondary Survey of Pain Attitudes - Brief (SOPA-B) Evaluates the patient's attitude to seven dimensions of the experience of chronic pain: control of pain, disability associated with pain, medical cues of pain, request for help from others when in pain, medication for pain, the influence of emotions on pain and pain as an indicator of physical damage. The scale consists of 30 items scored on a Likert scale from 0 to 4. Baseline and Six months
Secondary Pain Coping Inventory (PC) Instrument designed to evaluate the pain coping strategies used by patients with chronic pain. The scale consists of 34 items scored on a Likert scale from 1 to 4. Baseline and Six months
Secondary Short Form-36 Bodily Pain Scale (SF-36 BPS) It is one of the eight subscales of the SF-36 questionnaire (Ware, Kosinski & Keller, 1994) designed as a generic measure of health status for population studies. Baseline and Six months
Secondary Pain and Sleep Questionnaire (PSQ) Evaluates the impact of chronic pain on sleep quality. The scale consists of 8 items scored on a visual analog scale from 0 to 100. Baseline and Six months
Secondary Satisfaction with Life questionnaire (SWLS) 5-item brief scale designed to measure a person's overall cognitive judgments about their satisfaction with life. Baseline and Six months
Secondary WHO-5 Well Being Index 5 item scale designed to evaluate the subjective psychological well-being of the person. Baseline and Six months
See also
  Status Clinical Trial Phase
Completed NCT05982483 - Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain N/A
Completed NCT04744246 - Muscle Activity During Load Carriage in ROTC Cadets N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Active, not recruiting NCT03680846 - Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain N/A
Completed NCT05597189 - Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain N/A
Completed NCT05342181 - Static and Dynamic Core Stability Exercises in Potpartum Back Pain N/A
Completed NCT02955342 - Back and Neck Pain in Adolescence
Not yet recruiting NCT02536274 - "Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain" N/A
Completed NCT02704845 - Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain N/A
Recruiting NCT02237105 - The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Completed NCT02254694 - The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body N/A
Terminated NCT02239627 - Epidural Clonidine Versus Corticosteroid for Low Back Pain N/A
Completed NCT02609009 - Back Pain and Spinal Manipulation in Adolescent Scoliosis N/A
Completed NCT00986180 - NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain Phase 3
Terminated NCT00769626 - Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy Phase 3
Completed NCT00771758 - Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Phase 3
Withdrawn NCT00231374 - Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning N/A
Completed NCT00103675 - Sensor Measurement of Acupuncture Needle Manipulation Phase 1
Completed NCT00454064 - Cognitive-behavioural Treatment of Chronic Back Pain Phase 3